AbbVie

YTD

ALL

Trade AbbVie 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About ABBV

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology, oncology, including blood cancers, virology, hepatitis C virus (HCV) and human immunodeficiency virus (HIV), neurological disorders, such as Parkinson's, metabolic, comprising thyroid disease and complications associated with cystic fibrosis, pain associated with endometriosis, and other serious health conditions.

CEO

Robert A. Michael

CEORobert A. Michael

Employees

55,000

Employees55,000

Headquarters

North Chicago, Illinois

HeadquartersNorth Chicago, Illinois

Founded

2011

Founded2011

Employees

55,000

Employees55,000

ABBV Key Statistics

Market cap

334.31B

Market cap334.31B

Price-Earnings ratio

81.61

Price-Earnings ratio81.61

Dividend yield

3.33%

Dividend yield3.33%

Average volume

6.04M

Average volume6.04M

High today

$192.34

High today$192.34

Low today

$188.57

Low today$188.57

Open price

$191.60

Open price$191.60

Volume

5.21M

Volume5.21M

52 Week high

$218.66

52 Week high$218.66

52 Week low

$163.81

52 Week low$163.81

ABBV News

TipRanks 8h

AbbVie’s Pediatric Ulcerative Colitis Study: A Potential Game-Changer?

Abbvie ((ABBV)), Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Prem...

TipRanks 1d

AbbVie’s Oriahnn Study: Evaluating Hair Loss in Women with Uterine Fibroids

Abbvie ((ABBV)), Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Prem...

TipRanks 2d

AbbVie’s Pediatric Migraine Study: A Potential Game-Changer for Ubrogepant

Abbvie ((ABBV)), Abbvie (($CC:ABBV.CUR)) announced an update on their ongoing clinical study. Elevate Your Investing Strategy: Take advantage of TipRanks Prem...

Analyst ratings

60%

of 30 ratings

Buy

60%

Hold

40%

Sell

People also own

Based on the portfolios of people who own ABBV. This list is generated using Robinhood data, and it’s not a recommendation.